Ayurveda treatment for cervical erosio
Phase 2
Not yet recruiting
- Conditions
- Health Condition 1: N72- Inflammatory disease of cervix uteri
- Registration Number
- CTRI/2023/09/057739
- Lead Sponsor
- Parul Institute of Ayurved
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient who are willing for trial and ready to give informed written consent
Married
clinical diagnosed and confirmed case of cervical eosion
Patient having HPV infection LSIL HSIL
Chronisity of six months or more upto one year
Exclusion Criteria
Unmarried
Pregnant women
Known cases of TB cervical carcinoma HIV VDRL Hbsag positive patients sever anemia
Women with second and third degree of uterine prolapse
Women with STD
Women with any congenital anomalies of genital orgens
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of Nimbadi Yoni Varti in treating cervical erosion (N72)?
How does Pippalyadi Yoni Varti compare to standard-of-care treatments for inflammatory cervical diseases in terms of clinical outcomes?
Are there specific biomarkers that can predict patient response to Ayurvedic interventions like Nimbadi Yoni Varti in N72 cases?
What are the potential adverse events associated with Nimbadi Yoni Varti and Pippalyadi Yoni Varti in cervical erosion therapy?
What combination approaches or competitor drugs are being explored for cervical inflammation (N72) alongside Ayurvedic treatments?